Literature DB >> 25331682

Hepatitis E virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa).

Yousr Ben-Ayed1, Hela Hannachi, Nissaf Ben-Alaya-Bouafif, Emna Gouider, Henda Triki, Olfa Bahri.   

Abstract

The aims of this study are to determine seroprevalence of Hepatitis E virus (HEV) in Tunisian blood donors and to evaluate its risk of parenteral transmission. Sera collected from 426 blood donors were tested for HEV IgG by indirect ELISA. Individuals were recruited from two national transfusion centers, in the North and the South of the country. Seroprevalence of HEV IgG was then compared with two other groups with increased risk of exposure to parenterally transmitted agents: 80 hemophiliac and 286 hemodialysis patients. Among blood donors, the seroprevalence was estimated to be 4.5%. It was significantly higher in the hemophiliac and hemodialysis groups with 7.5% and 10.2%, respectively, (P = 0.002). No significant correlation was observed for this IgG 1 seroprevalence between age and sex among three studied groups. These results suggest that HEV has a high risk of parenteral transmission and confirm that the low endemicity of hepatitis E in Tunisia was observed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA virus; dialysis; hemophilia; parenteral risk

Mesh:

Substances:

Year:  2014        PMID: 25331682     DOI: 10.1002/jmv.24082

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Southern Tunisia: A still high endemicity area for hepatitis A.

Authors:  Houcine Neffatti; Patricia Lebraud; Corinne Hottelet; Jawher Gharbi; Taieb Challouf; Anne-Marie Roque-Afonso
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

2.  Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon.

Authors:  Mohamad Bachar Ismail; Imad Al Kassaa; Dima El Safadi; Sarah Al Omari; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

Review 3.  Transfusion-transmitted hepatitis E: What we know so far?

Authors:  Carmen Ka Man Cheung; Sunny Hei Wong; Alvin Wing Hin Law; Man Fai Law
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

4.  Hepatitis E virus infection in patients with acute non-A, non-B, non-C hepatitis in Central Brazil.

Authors:  Nara Rubia de Freitas; Edna Braz Rocha de Santana; Ágabo Macedo da Costa E Silva; Sueli Meira da Silva; Sheila Araújo Teles; Noemi Rovaris Gardinali; Marcelo Alves Pinto; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-13       Impact factor: 2.743

5.  Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors.

Authors:  Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman
Journal:  Open Forum Infect Dis       Date:  2021-04-13       Impact factor: 3.835

6.  Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil.

Authors:  Guilherme Bricks; Jorge Figueiredo Senise; Henrique Pott Junior; Giuliano Grandi; Amanda Passarini; Débora Bellini Caldeira; Dimas Carnaúba Junior; Hamilton Antonio Bonilha de Moraes; Celso Franscisco Hernandes Granato; Adauto Castelo
Journal:  Braz J Infect Dis       Date:  2018-02-27       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.